Suren Rana
Analyst · Morgan Stanley
Thanks, Elie. Good morning, everyone. Thank you for joining us today. As usual, I'll focus my initial remarks on the key highlights in the quarter laid out on Slide 5 of the presentation deck.
We reported ENI per share of $0.47 for the third quarter, which is 12% higher than the $0.42 we reported for the third quarter last year. While our revenue declined compared to the third quarter of last year due to the COVID-19-related market impact on our average AUM, our ENI increased due to the cost savings from our corporate repositioning and the continuing discipline on the OpEx by our affiliates.
And then our share repurchases in the first half of this year helped to further build the ENI on a per share basis. The ENI per share of $0.47 in the quarter is also 15% higher than the $0.41 we reported for the second quarter of this year, which reflects the increase in AUM and management fee revenue from the continuing market recovery, while our expenses remained largely flat compared to Q2.
We previously announced divestitures of our Barrow Hanley and Copper Rock affiliates. As a reminder, we completed the sale of Copper Rock early in the quarter in July, and we still expect the sale of Barrow Hanley to be completed in the fourth quarter.
Our net client cash flows in the quarter on a pro forma basis, that is excluding Barrow Hanley and Copper Rock, were negative $0.5 billion. But the annualized revenue impact of these flows was a positive $1.4 million as the fee on our inflows was higher than the fee on outflows.
In the Alternatives segment, we had net inflows of $0.7 billion in this quarter, which reflects a modest pickup in the pace of our fundraising, but we still continue to see a delay in the timing of our fund raise because of the restrictions imposed by the pandemic. As we have previously discussed, we still expect the bulk of our fundraising to come in 2021 and 2022.
Our investment performance remains generally stable. In the Quant & Solutions segment, our investment performance continued to be strong, with 45%, 49%, and 88% of strategies by revenue beating their respective benchmarks over the prior 3-, 5- and 10-year periods.
Moving to capital management. We reduced the borrowings on our corporate revolver from $130 million at the end of Q2 to $80 million at the end of Q3, which reduced our net debt ratio to 1.5x compared to 1.7x earlier. Additionally, we fully paid off the remaining $22 million of outstanding amount on our nonrecourse seed facility since we have an adequate amount of capital to seed new strategies for our affiliates.
Now as we look toward closing the Barrow Hanley sale in the fourth quarter, we intend to use the proceeds from that closing to fully pay down our revolver, and we plan to use part of the proceeds towards repurchases. We're still on track to deliver annual cost savings of over $20 million by Q1 of 2021 from the previously announced repositioning of our corporate center.
Next few slides highlights the strength of our differentiated business mix, with 87% of the ENI post the divestitures coming from Quant & Solutions and Alternatives segments. We already walked through this a fair bit on our last earnings call, so I'd like to now move to Slide 14 to provide some more color on our flows by segment.
Looking at the chart on the left-hand side of the page, in the second column, the pro forma column, you'll see in the Alternatives segment, we posted net inflows of $0.7 billion. You may recall, this number was a small positive in Q2. In the pro forma Liquid Alpha segment, that's excluding Barrow Hanley, we posted net inflows of $1.1 billion for the quarter, and that number was positive $0.1 billion in Q2. In the Quant & Solutions segment, we had net outflows of $2.3 billion this quarter. In Q2, the segment had net inflows of $0.3 billion. The net outflow in Q3 was primarily a result of 2 large withdrawals driven by rebalancing considerations.
Now I'd like to turn the call back to the operator, and I'm happy to answer questions at this point.